An interventional study of CWRT with low frequency transcutaneous electrical nerve stimulation and CWRT with sham-low frequency transcutaneous electrical nerve stimulation in COPD, Physical Activity and Rehabilitation, sponsored by Groupe Hospitalier du Havre. Terminated at 1 site in France. Open to participants aged 35 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-01-21.
Sponsored by Groupe Hospitalier du Havre · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre — 3 open to participants now, 3 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Groupe Hospitalier du Havre.
Among the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre, this one is the only one that started in 2021, is one of 5 with no phase, and was the 2nd registered.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →3 of the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre are open now, in 1 country. Recruiting first, the newest first:
Groupe Hospitalier du Havre · Sites in France
Ages 18+
Groupe Hospitalier du Havre · Sites in France
Ages 18+
Groupe Hospitalier du Havre
Ages 18+ · Healthy volunteers
By country, each count listing its studies:
Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.
This study: 35 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 1 started in 2021.
This study's enrollment of 2 is below the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 22 across the 5 interventional studies, 30 across the 5 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Groupe Hospitalier du Havre is the lead sponsor of 22 studies on the registry; 6 are open to participants now.
1 of the studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07371754Groupe Hospitalier du HavreShear Wave Elastography of Intercostal Muscles for the Non-invasive Assessment of the Work of BreathinG | 2027-03-01 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. Several studies showed that transcutaneous electrical nerve stimulation (TENS) could improve dyspnea and pulmonary function. The aim of this study is to assess the acute effect of TENS on exercise tolerance in post-exacerbation COPD patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will perform one Constant Work-Rate Exercise Test at 80% of maximum workload with low frequency TENS
Other: CWRT with low frequency transcutaneous electrical nerve stimulation
Patients will perform one Constant Work-Rate Exercise Test at 80% of maximum workload with low frequency sham-TENS
Other: CWRT with sham-low frequency transcutaneous electrical nerve stimulation
4 self adhesive surface electrodes will be positioned by pair on quadriceps. Patients will have a low frequency TENS for 20 min at rest. During this period, intensity will be increased every 5 minutes to the maximum tolerated by the patient (below pain threshold, sensation strong but comfortable). Thereafter, intensity is not increased anymore during the test. Current characteristics : Rehab 400, CefarCompex 5Hz 200 µs frequency bidirectional
4 self adhesive surface electrodes are positioned by pair on quadriceps. Patients will have a sham-low frequency TENS for 20 min at rest. During this period, intensity will be increased for 1 minute to the maximum tolerated by the patient. After this procedure, intensity will be progressively setted back to 1mA. Current characteristics : Rehab 400, CefarCompex 5Hz 200 µs frequency bidirectional
comparison of exercise tolerance
Comparison of endurance time (Tlim, in second) during constant workload testing (CWRET) under 2 conditions
Time frame: two CWRET will be carried out in different days, separate from 24 hours minimum for a total time frame of 5 days maximum
Difference in peripheral muscle oxygenation
Muscle oxygenation (arbitrary unit) will be evaluated using Near-infrared spectroscopy technology.
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in Dyspnea
Difference in dyspnea using Modified Borg Scale (0 - 10 points) 0=no dyspnea ; 10 = maximal effort
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in Oxygen Saturation
Difference in Oxygen Saturation (%) using a pulse oximetry (SpO2)
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in Cardiac Frequency
Difference in Cardiac Frequence (bpm) using a pulse oximetry
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in muscular fatigue
Difference in muscular fatigue using Modified Borg Scale (0 - 10 points) 0=no muscular fatigue ; 10 = maximal effort
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in oxygen consumption
Difference in oxygen consumption (milliliters per minute) will be measured breath-by-breath using a computer-based exercise system
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in carbon dioxide production
Difference in carbon dioxide production (milliliters per minute) will be measured breath-by-breath using a computer-based exercise system
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in minute ventilation
Difference in minute ventilation (liters per minute) will be measured breath-by-breath using a computer-based exercise system
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in tidal volume
Difference in tidal volume (Liters) will be measured breath-by-breath using a computer-based exercise system
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in respiratory rate
Difference in respiratory rate (cycles per minute) will be measured breath-by-breath using a computer-based exercise system
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in inspiratory capacity
Difference in inspiratory capacity (Liters) will be measured breath-by-breath using a computer-based exercise system
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Difference in respiratory quotient
Difference in respiratory quotient (ratio) will be measured breath-by-breath using a computer-based exercise system
Time frame: The outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 5 days maximum. Data will be continuously collected during exercise
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Oct 2021 to primary completion in Oct 2023, 23 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Groupe Hospitalier du Havre